Big Pharma’s Anti-Marijuana Stance Aims to Crush the Competition, Activists Say

Pharmaceutical company Insys spent $500,000 to block legalization in Arizona. Five months later it won approval for a cannabis-derived medical drug.

Leave a Reply

Your email address will not be published. Required fields are marked *